CD48 Is a Key Molecule of Immunomodulation Affecting Prognosis in Glioma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s198762
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Immunomodulation Is the Key to Cardiac Repair

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2017English

Cathepsin D Is a Potential Serum Marker for Poor Prognosis in Glioma Patients

Cancer Research
Cancer ResearchOncology
2005English

EZH2 Overexpression Is Associated With Poor Prognosis in Patients With Glioma

Oncotarget
Oncology
2016English

Serpin Peptidase Inhibitor, Clade a Member 3 (SERPINA3), Is Overexpressed in Glioma and Associated With Poor Prognosis in Glioma Patients

OncoTargets and Therapy
OncologyPharmacology
2017English

Decreased Expression of the SPOP Gene Is Associated With Poor Prognosis in Glioma

International Journal of Oncology
Cancer ResearchOncology
2014English

Epigenetic Silencing of KAZALD1 Confers a Better Prognosis and Is Associated With Malignant Transformation/Progression in Glioma

Oncology Reports
MedicineCancer ResearchOncology
2013English

Exosomal microRNA‑210 Is a Potentially Non‑invasive Biomarker for the Diagnosis and Prognosis of Glioma

Oncology Letters
Cancer ResearchOncology
2020English

IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?

Oncologist
Cancer ResearchMedicineOncology
2010English

Nuclear FABP7 Immunoreactivity Is Preferentially Expressed in Infiltrative Glioma and Is Associated With Poor Prognosis in EGFR-overexpressing Glioblastoma

BMC Cancer
Cancer ResearchOncologyGenetics
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy